• FirefoxInstall the new Firefox »
  •  Dow Up0.12% Nasdaq Up0.27%

    Spectrum Pharmaceuticals, Inc. (SPPI)

    -NasdaqGS
    6.22 Down 0.09(1.35%) 2:42PM EST - Nasdaq Real Time Price
    Add to Portfolio
    Income StatementGet Income Statement for:
    View: Annual Data | Quarterly DataAll numbers in thousands
    Period EndingSep 30, 2014Jun 30, 2014Mar 31, 2014Dec 31, 2013
    Total Revenue 47,990   46,855   40,124   41,516  
    Cost of Revenue6,530  6,156  6,278  6,309  
    Gross Profit 41,460   40,699   33,846   35,207  
    Operating Expenses
    Research Development14,420  11,335  29,497  10,760  
    Selling General and Administrative24,125  25,399  23,403  25,714  
    Non Recurring -   -   -   -  
    Others7,042  5,361  5,360  5,245  
    Total Operating Expenses -   -   -   -  
    Operating Income or Loss (4,127) (1,396) (24,414) (6,512)
    Income from Continuing Operations
    Total Other Income/Expenses Net(1,574)(1,492)(1,082)3,537  
    Earnings Before Interest And Taxes(5,701)(2,888)(25,496)(5,167)
    Interest Expense2,361  1,976  2,067  (1,542)
    Income Before Tax(8,062)(4,864)(27,563)(3,625)
    Income Tax Expense3,477  (1,301)78  35,747  
    Minority Interest -   -   -   -  
    Net Income From Continuing Ops(11,539)(3,563)(27,641)(39,372)
    Non-recurring Events
    Discontinued Operations -   -   -   -  
    Extraordinary Items -   -   -   -  
    Effect Of Accounting Changes -   -   -   -  
    Other Items -   -   -   -  
    Net Income (11,539) (3,563) (27,641) (39,372)
    Preferred Stock And Other Adjustments -   -   -   -  
    Net Income Applicable To Common Shares (11,539) (3,563) (27,641) (39,372)

    Sign Up for a Free Trial to EDGAR Online Premium!
    Get the critical business and financial information you need for more than 15,000 U.S. public companies.
    Sign Up Now - Learn More

    Currency in USD.